Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Terminal Care | 11 | 2016 | 112 | 2.730 |
Why?
|
| Advance Care Planning | 6 | 2016 | 41 | 1.660 |
Why?
|
| Attitude to Death | 5 | 2013 | 38 | 1.300 |
Why?
|
| Dementia | 6 | 2013 | 429 | 1.040 |
Why?
|
| Palliative Care | 8 | 2021 | 443 | 1.030 |
Why?
|
| Advance Directives | 4 | 2016 | 32 | 0.990 |
Why?
|
| Terminally Ill | 4 | 2013 | 26 | 0.980 |
Why?
|
| Decision Making | 6 | 2017 | 687 | 0.920 |
Why?
|
| Pharmacists | 2 | 2021 | 102 | 0.890 |
Why?
|
| Veterans | 9 | 2015 | 1792 | 0.730 |
Why?
|
| Hospices | 1 | 2021 | 8 | 0.710 |
Why?
|
| Cross-Cultural Comparison | 2 | 2013 | 57 | 0.670 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 139 | 0.630 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 435 | 0.620 |
Why?
|
| Life Support Care | 2 | 2011 | 52 | 0.600 |
Why?
|
| Geriatrics | 4 | 2020 | 74 | 0.570 |
Why?
|
| Nerve Net | 1 | 2021 | 264 | 0.560 |
Why?
|
| Schizophrenia | 1 | 2021 | 326 | 0.550 |
Why?
|
| Cancer Pain | 1 | 2017 | 25 | 0.510 |
Why?
|
| Depression | 4 | 2022 | 1317 | 0.480 |
Why?
|
| Social Values | 1 | 2015 | 45 | 0.460 |
Why?
|
| Depressive Disorder | 2 | 2009 | 457 | 0.440 |
Why?
|
| Drug Monitoring | 2 | 2009 | 288 | 0.440 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2013 | 87 | 0.440 |
Why?
|
| Drug Utilization | 2 | 2013 | 162 | 0.430 |
Why?
|
| Personal Autonomy | 2 | 2013 | 206 | 0.400 |
Why?
|
| Writing | 1 | 2013 | 59 | 0.380 |
Why?
|
| Professional Competence | 1 | 2013 | 96 | 0.380 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 480 | 0.370 |
Why?
|
| Personality | 1 | 2013 | 111 | 0.370 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 480 | 0.360 |
Why?
|
| Euthanasia, Passive | 1 | 2011 | 9 | 0.340 |
Why?
|
| Communication | 1 | 2015 | 531 | 0.340 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 170 | 0.340 |
Why?
|
| Hypertension | 2 | 2010 | 1352 | 0.330 |
Why?
|
| Physician's Role | 2 | 2009 | 165 | 0.330 |
Why?
|
| Prefrontal Cortex | 2 | 2024 | 212 | 0.330 |
Why?
|
| Brain | 2 | 2024 | 3186 | 0.320 |
Why?
|
| Health Care Rationing | 2 | 2020 | 58 | 0.310 |
Why?
|
| Antihypertensive Agents | 2 | 2010 | 419 | 0.310 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2009 | 36 | 0.300 |
Why?
|
| Professional Role | 1 | 2009 | 75 | 0.290 |
Why?
|
| Students, Medical | 1 | 2013 | 341 | 0.290 |
Why?
|
| Blindness | 1 | 2009 | 71 | 0.290 |
Why?
|
| Aged | 16 | 2020 | 20894 | 0.280 |
Why?
|
| Antidepressive Agents | 2 | 2008 | 328 | 0.270 |
Why?
|
| Humans | 34 | 2024 | 130422 | 0.270 |
Why?
|
| Geriatric Assessment | 1 | 2009 | 184 | 0.270 |
Why?
|
| Betacoronavirus | 2 | 2020 | 284 | 0.250 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 6781 | 0.250 |
Why?
|
| Focus Groups | 3 | 2013 | 232 | 0.240 |
Why?
|
| Male | 22 | 2024 | 64527 | 0.240 |
Why?
|
| Thromboembolism | 1 | 2007 | 95 | 0.240 |
Why?
|
| Warfarin | 1 | 2007 | 123 | 0.230 |
Why?
|
| Qualitative Research | 4 | 2019 | 695 | 0.230 |
Why?
|
| Hypotension, Orthostatic | 1 | 2005 | 19 | 0.230 |
Why?
|
| Medication Adherence | 1 | 2009 | 332 | 0.230 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 363 | 0.220 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 374 | 0.220 |
Why?
|
| Quality of Life | 5 | 2021 | 2071 | 0.220 |
Why?
|
| Drug Therapy | 1 | 2005 | 84 | 0.220 |
Why?
|
| Gastrostomy | 1 | 2005 | 86 | 0.210 |
Why?
|
| Hospitalization | 1 | 2013 | 1927 | 0.210 |
Why?
|
| Inpatients | 3 | 2021 | 550 | 0.210 |
Why?
|
| Feeding and Eating Disorders | 1 | 2005 | 71 | 0.210 |
Why?
|
| Blood Pressure | 1 | 2010 | 1337 | 0.210 |
Why?
|
| Critical Illness | 1 | 2008 | 616 | 0.210 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 420 | 0.210 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2024 | 68 | 0.200 |
Why?
|
| Female | 20 | 2024 | 70285 | 0.200 |
Why?
|
| Caregivers | 1 | 2009 | 572 | 0.200 |
Why?
|
| Hemorrhage | 1 | 2007 | 492 | 0.200 |
Why?
|
| Primary Health Care | 1 | 2009 | 769 | 0.190 |
Why?
|
| Pandemics | 2 | 2020 | 1153 | 0.190 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2022 | 11 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2017 | 771 | 0.190 |
Why?
|
| Enteral Nutrition | 1 | 2005 | 282 | 0.180 |
Why?
|
| Neoplasms | 1 | 2017 | 2944 | 0.180 |
Why?
|
| Anticoagulants | 1 | 2007 | 601 | 0.180 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2021 | 6 | 0.170 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2021 | 32 | 0.170 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2021 | 38 | 0.170 |
Why?
|
| Cohort Studies | 5 | 2009 | 5069 | 0.170 |
Why?
|
| Middle Aged | 9 | 2024 | 28383 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3815 | 0.170 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 34 | 0.160 |
Why?
|
| Health Planning Guidelines | 1 | 2020 | 33 | 0.160 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2020 | 66 | 0.160 |
Why?
|
| Chickens | 1 | 2020 | 269 | 0.160 |
Why?
|
| Suicide, Assisted | 1 | 2019 | 11 | 0.160 |
Why?
|
| Glycine | 1 | 2020 | 158 | 0.150 |
Why?
|
| Acute-On-Chronic Liver Failure | 1 | 2020 | 73 | 0.150 |
Why?
|
| Physicians | 2 | 2019 | 634 | 0.140 |
Why?
|
| Patient Selection | 2 | 2017 | 721 | 0.140 |
Why?
|
| Adult | 7 | 2024 | 31127 | 0.140 |
Why?
|
| Prevalence | 3 | 2013 | 2685 | 0.140 |
Why?
|
| Oncologists | 1 | 2017 | 32 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2024 | 1090 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2004 | 890 | 0.130 |
Why?
|
| Dietary Supplements | 1 | 2020 | 448 | 0.120 |
Why?
|
| Resuscitation Orders | 1 | 2016 | 31 | 0.120 |
Why?
|
| California | 1 | 2016 | 127 | 0.120 |
Why?
|
| Antipsychotic Agents | 2 | 2013 | 364 | 0.120 |
Why?
|
| United States | 8 | 2020 | 11827 | 0.120 |
Why?
|
| Nursing Homes | 1 | 2016 | 88 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2013 | 17614 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2019 | 790 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2020 | 797 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2017 | 718 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 701 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 341 | 0.100 |
Why?
|
| Altruism | 1 | 2013 | 23 | 0.100 |
Why?
|
| Young Adult | 3 | 2024 | 9995 | 0.100 |
Why?
|
| Empathy | 1 | 2013 | 68 | 0.100 |
Why?
|
| Trust | 1 | 2013 | 88 | 0.100 |
Why?
|
| Benzodiazepines | 1 | 2013 | 104 | 0.090 |
Why?
|
| Delirium | 1 | 2013 | 64 | 0.090 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 4002 | 0.090 |
Why?
|
| Hospice Care | 1 | 2011 | 31 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2013 | 3682 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2015 | 1452 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2017 | 1100 | 0.080 |
Why?
|
| Self Report | 1 | 2013 | 555 | 0.080 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2010 | 35 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 110 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2013 | 429 | 0.070 |
Why?
|
| Patient Satisfaction | 2 | 2011 | 451 | 0.070 |
Why?
|
| Dysthymic Disorder | 1 | 2009 | 7 | 0.070 |
Why?
|
| Memantine | 1 | 2009 | 16 | 0.070 |
Why?
|
| Cultural Diversity | 1 | 2009 | 79 | 0.070 |
Why?
|
| Grief | 1 | 2009 | 21 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2010 | 828 | 0.070 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2009 | 84 | 0.070 |
Why?
|
| Professional-Family Relations | 1 | 2009 | 95 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2013 | 1065 | 0.070 |
Why?
|
| Curriculum | 1 | 2013 | 784 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1543 | 0.070 |
Why?
|
| Length of Stay | 1 | 2013 | 1395 | 0.070 |
Why?
|
| Health Planning | 1 | 2007 | 16 | 0.060 |
Why?
|
| International Normalized Ratio | 1 | 2007 | 45 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 3626 | 0.060 |
Why?
|
| Informed Consent | 1 | 2009 | 348 | 0.060 |
Why?
|
| Outpatients | 2 | 2005 | 266 | 0.060 |
Why?
|
| Ethics, Medical | 1 | 2009 | 398 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2013 | 812 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2007 | 175 | 0.060 |
Why?
|
| Prazosin | 1 | 2005 | 16 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2009 | 555 | 0.060 |
Why?
|
| Furosemide | 1 | 2005 | 35 | 0.060 |
Why?
|
| Lisinopril | 1 | 2005 | 27 | 0.060 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 730 | 0.060 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 34 | 0.060 |
Why?
|
| Hydrochlorothiazide | 1 | 2005 | 67 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2010 | 1223 | 0.050 |
Why?
|
| Psychomotor Agitation | 1 | 2004 | 54 | 0.050 |
Why?
|
| Gray Matter | 1 | 2024 | 50 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 499 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2007 | 400 | 0.050 |
Why?
|
| Hospitals, Veterans | 1 | 2005 | 345 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2007 | 509 | 0.050 |
Why?
|
| Aggression | 1 | 2004 | 216 | 0.050 |
Why?
|
| Amygdala | 1 | 2022 | 76 | 0.040 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2001 | 27 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2007 | 680 | 0.040 |
Why?
|
| Creatine | 1 | 2020 | 38 | 0.040 |
Why?
|
| Animal Feed | 1 | 2020 | 79 | 0.040 |
Why?
|
| District of Columbia | 1 | 2019 | 16 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 2020 | 122 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2024 | 544 | 0.040 |
Why?
|
| Risk Factors | 1 | 2013 | 10942 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 764 | 0.040 |
Why?
|
| Arginine | 1 | 2020 | 336 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 149 | 0.030 |
Why?
|
| Anxiety | 1 | 2022 | 1001 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2008 | 12860 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 279 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 1098 | 0.020 |
Why?
|
| Bibliometrics | 1 | 2011 | 38 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4894 | 0.020 |
Why?
|
| Pain Management | 1 | 2011 | 204 | 0.020 |
Why?
|
| Health Resources | 1 | 2005 | 126 | 0.010 |
Why?
|
| Urban Population | 1 | 2001 | 273 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 33892 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 2835 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 875 | 0.010 |
Why?
|